ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Corbett, Harriet Jane ^a,b   Connell, Marilyn Gwen ^a   Fernig, David Garth ^a   Losty, Paul Damion ^a,b   Jesudason, Edwin Chitran ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITROFEN; PROTEIN P42; PROTEIN P44; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; DIPHENYL ETHER DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DIAPHRAGM HERNIA; DISEASE MODEL; FEMALE; HYPERTENSION; LUNG; METABOLISM; NEWBORN; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANGIOPOIETIN-1; ANIMALS; ANIMALS, NEWBORN; BONE MORPHOGENETIC PROTEIN RECEPTORS; DISEASE MODELS, ANIMAL; FEMALE; HERNIA, DIAPHRAGMATIC; HYPERTENSION; LUNG; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHENYL ETHERS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

EID: 84859940324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035364     Document Type: Article

References (47)

1. Lane KB, Machado RD, Pauciulo MW, Thomson JR, et al. International PPH Consortium (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26: 81-84.
2. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, et al. (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68: 92-102.
3. Harrison RE, Flanagan JA, Sankelo M, Abdalla SA, Rowell J, et al. (2003) Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 40: 865-871.
4. Du L, Sullivan CC, Chu D, Cho AJ, Kido M, et al. (2003) Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348: 500-509.
5. Zhao YD, Campbell AI, Robb M, Ng D, Stewart DJ, (2003) Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 92: 984-991.
6. Brindle NP, Saharinen P, Alitalo K, (2006) Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98: 1014-1023.
7. Kugathasan L, Ray JB, Deng Y, Rezaei E, Dumont DJ, et al. (2009) The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 206: 2221-2234.
8. Finer NN, Barrington KJ, (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev Oct 18 (4): CD000399.
9. Mugford M, Elbourne D, Field D, (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev Jul 16 (3): CD001340.
10. Kluth D, Kangah R, Reich P, Tenbrinck R, Tibboel D, et al. (1990) Nitrofen-induced diaphragmatic hernias in rats: an animal model. J Pediatr Surg 25: 850-854.
11. Tenbrinck R, Gaillard JL, Tibboel D, Kluth D, Lachmann B, et al. (1992) Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 27: 862-865.
12. Coleman C, Zhao J, Gupta M, Buckley S, Tefft JD, et al. (1998) Inhibition of vascular and epithelial differentiation in murine nitrofen-induced diaphragmatic hernia. Am J Physiol 274: L636-646.
13. Okoye BO, Losty PD, Lloyd DA, Gosney JR, (1998) Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 33: 76-80.
14. Kanai M, Kitano Y, von Allmen D, Davies P, Adzick NS, et al. (2001) Fetal tracheal occlusion in the rat model of nitrofen-induced congenital diaphragmatic hernia: tracheal occlusion reverses the arterial structural abnormality. J Pediatr Surg 36: 839-845.
15. Taira Y, Yamataka T, Miyazaki E, Puri P, (1998) Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia. Pediatr Surg Int 14: 30-35.
16. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD, (2000) Heparin and in-vitro experimental lung hypoplasia. Pediatr Surg Int 16: 247-251.
17. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD, (2000) In vitro effects of growth factors on lung hypoplasia in a model of congenital diaphragmatic hernia. J Pediatr Surg 35: 914-922.
18. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD, (2000) Cell proliferation and apoptosis in experimental lung hypoplasia. J Pediatr Surg 35: 129-133.
19. Jesudason EC, Connell MG, Fernig DG, Lloyd DA, Losty PD, (2000) Early lung malformations in congenital diaphragmatic hernia. J Pediatr Surg 35: 124-127.
20. Thompson SM, Connell MG, van Kuppevelt TH, Xu R, Turnbull JE, et al. (2011) Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation? BMC Dev Biol 11: 38 Available:http://www.biomedcentral.com/1471-213X/11/38.
21. Featherstone NC, Connell MG, Fernig DG, Wray S, Burdyga TV, et al. (2006) Airway smooth muscle dysfunction precedes teratogenic congenital diaphragmatic hernia and may contribute to hypoplastic lung morphogenesis. Am J Respir Cell Mol Biol 35: 571-578.
22. Cilley RE, Zgleszewski SE, Krummel TM, Chinoy MR, (1997) Nitrofen dose-dependent gestational day-specific murine lung hypoplasia and left-sided diaphragmatic hernia. Am J Physiol 272: L362-371.
23. Chinoy MR, Graybill MM, Miller SA, Lang CM, Kauffman GL, (2002) Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs. Am J Physiol Lung Cell Mol Physiol 283: L60-66.
24. Geggel RL, Murphy JD, Langleben D, Crone RK, Vacanti JP, et al. (1985) Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr 107: 457-464.
25. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, et al. (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54: S20-31.
26. Nohe A, Keating E, Knaus P, Petersen NO, (2004) Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291-299.
27. Frank DB, Lowery J, Anderson L, Brink M, Reese J, et al. (2008) Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 294: L98-109.
28. Takahashi H, Goto N, Kojima Y, Tsuda Y, Morio Y, et al. (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L450-458.
29. Long L, MacLean MR, Jeffery TK, Morecroft I, Yang X, et al. (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98: 818-827.
30. West J, Tada Y, Fagan KA, Steudel W, Fouty BW, et al. (2005) Suppression of type II bone morphogenic protein receptor in vascular smooth muscle induces pulmonary arterial hypertension in transgenic mice. Chest 128: 553S.
31. Yu PB, Beppu H, Kawai N, Li E, Bloch KD, (2005) Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J Biol Chem 280: 24443-24450.
32. Yang X, Long L, Southwood M, Rudarakanchana N, Upton PD, et al. (2005) Dysfunctional Smad signaling contributes to Abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96: 1053-1063.
33. Ihida-Stansbury K, McKean DM, Lane KB, Loyd JE, Wheeler LA, et al. (2006) Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 291: L694-702.
34. Reynolds AM, Holmes MD, Danilov SM, Reynolds PN, (2012) Targeted gene delivery of BMPR-2 attenuates pulmonary hypertension. Eur Respir J 39: 329-343.
35. Rocha GM, Bianchi RF, Severo M, Rodrigues MM, Baptista MJ, et al. (2008) Congenital diaphragmatic hernia- the neonatal period (part I). Eur J Pediatr Surg 18: 219-223.
36. Gallot D, Boda C, Ughetto S, Perthus I, Robert-Gnansia E, et al. (2007) Prenatal detection and outcome of congenital diaphragmatic hernia: a French registry-based study. Ultrasound Obstet Gynecol 29: 276-283.
37. Thérèse P, (2006) Persistent pulmonary hypertension of the newborn. Paediatr Respir Rev 7: S175-176.
38. Solari V, Piotrowska AP, Puri P, (2003) Expression of heme oxygenase-1 and endothelial nitric oxide synthase in the lung of newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. J Pediatr Surg 38: 808-813.
39. Okoye BO, Losty PD, Fisher MJ, Wilmott I, Lloyd DA, (1998) Effect of dexamethasone on endothelial nitric oxide synthase in experimental congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed 78: F204-208.
40. Stewart DJ, (2005) Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma? Circ Res 96: 1033-1035.
41. Boucherat O, Franco-Montoya ML, Delacourt C, Martinovic J, Masse V, et al. (2010) Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF. Am J Physiol Lung Cell Mol Physiol 298: L849-856.
42. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, et al. (2002) Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282: L811-823.
43. Richter A, Yeager ME, Zaiman A, Cool CD, Voelkel NF, et al. (2004) Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 170: 1340-1348.
44. Chen C, Chen H, Sun J, Bringas P Jr, Chen Y, et al. (2005) Smad1 expression and function during mouse embryonic lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol 288: L1033-1039.
45. Kling DE, Narra V, Islam S, Kinane TB, Alessandrini A, et al. (2001) Decreased mitogen activated protein kinase activities in congenital diaphragmatic hernia-associated pulmonary hypoplasia. J Pediatr Surg 36: 1490-1496.
46. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
47. Sun L, Cui M, Wang Z, Feng X, Mao J, et al. (2007) Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun 357: 779-784.